Psychosis happens when several biological systems in the brain go off-track at once, and no single cause explains it on its own. At minimum, it involves disrupted chemical signaling, genetic vulnerability, and usually some environmental push that tips the balance. The reason psychosis remains so hard to predict and treat is that these ingredients combine differently in every person, and researchers are still piecing together how they interact. What has become clear in recent decades is that the old idea of a single “broken” brain chemical is far too simple.
The Dopamine Story and Why It Is Incomplete
The most established chemical explanation for psychosis centers on dopamine. The idea dates back to the 1950s, when the first antipsychotic drugs were discovered almost by accident and later found to work by blocking dopamine receptors. Since then, the prevailing model has been that psychotic symptoms arise from dysregulated dopamine activity in the brain, particularly an excess of dopamine signaling in certain deep brain regions.1PubMed Central. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes This explains some things well. Drugs that flood the brain with dopamine, like amphetamines, can produce psychotic symptoms nearly identical to those of schizophrenia, and the symptoms tend to resolve faster once the drug clears.2PubMed Central. Amphetamine-induced psychosis–a separate diagnostic entity or primary psychosis triggered in the vulnerable? Every antipsychotic medication in clinical use blocks dopamine to some degree.
But dopamine cannot be the whole explanation. Many people with psychosis do not respond well to dopamine-blocking drugs, and the negative symptoms of psychosis, like social withdrawal and flattened emotions, do not map neatly onto dopamine excess. Over the past two decades, researchers have increasingly focused on another signaling system: the glutamate pathway, specifically a receptor called NMDA. Evidence from genetics, pharmacology, and brain chemistry points to reduced NMDA receptor function as a major contributor to schizophrenia.3PubMed Central. The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment In practical terms, this means the brain’s main excitatory signaling system is underperforming. Drugs that block NMDA receptors, like ketamine and PCP, reliably produce psychotic-like experiences in healthy people, which gave researchers a strong clue that this system matters.
The dopamine and glutamate stories are connected. NMDA receptors help regulate dopamine release, so when NMDA function drops, dopamine signaling in certain brain areas can spike. Thinking of psychosis as a dopamine problem alone is a bit like noticing the sprinklers went off and blaming the water without asking who pulled the fire alarm.
Genetic Risk Is Real but Scattered
Psychosis runs in families, but it does not follow a simple inheritance pattern. There is no single “psychosis gene.” Instead, risk comes from hundreds or even thousands of common genetic variants, each contributing a tiny nudge. Researchers summarize this using polygenic risk scores, which add up all those small effects. Studies in large populations show that higher polygenic scores are associated with greater risk of psychotic disorders, and that this risk operates alongside the effects of rare chromosomal abnormalities called copy number variants.4JAMA Psychiatry. Recurrent Copy Number Variants and Psychiatric Outcomes in the Context of Polygenic Scores Interestingly, for schizophrenia specifically, having a low polygenic score seemed to buffer some of the risk carried by those rare variants, suggesting the two genetic layers interact in ways researchers are still working out.
Copy number variants, which are deletions or duplications of stretches of DNA, also matter. Carriers of certain rare deletions tend to score higher on measures of mood and anxiety problems, though the individual effect sizes are small.5PubMed Central. Impact of Copy Number Variants and Polygenic Risk Scores on Psychopathology in the UK Biobank The picture that emerges is one of accumulated genetic load rather than a single decisive mutation. Two people could carry the same number of risk variants and have very different outcomes depending on their environment and the specific combination of genes involved.
Synaptic Pruning and the Complement System
One of the most striking genetic discoveries in psychosis research involves a gene called C4, part of the immune system’s complement pathway. During adolescence and early adulthood, the brain undergoes a normal process of trimming excess connections between neurons. This “synaptic pruning” is essential for efficient brain circuits. The C4 gene, specifically the C4A variant, appears to play a direct role in tagging synapses for removal. In mice, C4 mediated synapse elimination during postnatal development.6PubMed Central. Schizophrenia risk from complex variation of complement component 4 In humans, greater expression of C4A in the brain is linked to higher schizophrenia risk.
The connection was tested more directly in engineered mice that overexpressed human C4A. Those mice showed reduced cortical synapse density, increased immune-cell engulfment of synapses, and altered behavior.7PubMed Central. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice The finding fits with a long-observed pattern: people who develop schizophrenia often show reduced gray matter and fewer synaptic connections in brain imaging, particularly in the prefrontal cortex. If the pruning machinery is set too aggressively, you end up removing connections the brain still needs, and the timing, during adolescence and early adulthood, aligns with when psychotic disorders most commonly emerge.
An intriguing detail from the same research is that mice completely lacking C4 had normal numbers of cortical synapses, meaning complement is not strictly necessary for routine pruning.7PubMed Central. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice The problem is not that pruning happens at all but that too much C4A tips the balance toward excessive removal.
Cannabis and Other Environmental Triggers
Genetic vulnerability alone does not usually produce psychosis. Something in the environment typically pushes a susceptible brain across the threshold. Cannabis is the most-studied trigger, and the evidence is clearer than many people realize: it is not just about whether someone uses cannabis but what kind and how often.
In a case-control study of people experiencing their first episode of psychosis, those who used high-potency cannabis (“skunk”-type strains, which are rich in THC) showed roughly a threefold increase in risk compared to people who had never used cannabis. Daily use of high-potency cannabis carried an even steeper risk, with about a fivefold increase.8PubMed. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study Among people with first-episode psychosis, a much larger share reported using high-potency cannabis compared to healthy controls, consistent with the idea that THC itself is the ingredient increasing risk.9PubMed Central. High-potency cannabis and the risk of psychosis This does not mean every daily cannabis user will develop psychosis. Most will not. But for someone with underlying genetic vulnerability, heavy use of high-THC products can be the environmental push that matters.
Childhood adversity is another well-documented trigger. Trauma, neglect, and growing up in densely urban environments have all been linked to psychotic disorders. Research suggests that social isolation and what some researchers call “social defeat,” the chronic experience of being at a disadvantage relative to others, may be part of why urban upbringing carries risk. These factors may intensify the effects of childhood neglect.10PubMed Central. Childhood trauma and childhood urbanicity in relation to psychotic disorder
Stress in general plays a recognized role in both triggering first episodes and causing relapses. The biological pathways linking stress to psychosis involve cortisol and inflammatory markers. Abnormalities in these stress-response systems have been found in people with psychotic disorders, suggesting that chronic stress literally reshapes the brain’s chemical environment in ways that make psychotic symptoms more likely.11PubMed Central. From stress to psychosis: whom, how, when and why?
When the Brain’s Prediction Engine Misfires
A more recent way of understanding psychosis focuses on how the brain constructs reality moment to moment. Your brain does not passively receive sensory information. It actively predicts what it expects to perceive, then compares those predictions with incoming data. When something unexpected happens, the brain updates its model. In psychosis, this system appears to go wrong in a specific way: the brain over-weights its own prior beliefs and under-weights what the senses are actually reporting.12PubMed Central. The Predictive Coding Account of Psychosis
Under this framework, hallucinations can be understood as the brain generating a strong perceptual prediction, say an internal voice, and treating it as real because the system no longer properly checks that prediction against incoming silence. Delusions may involve a different kind of failure, where the brain forms strong explanatory beliefs and can no longer update them when confronted with contradicting evidence. Hallucinations and delusions may relate to distinct alterations in this prediction system, which helps explain why the two symptoms, though they often appear together, do not always track each other.12PubMed Central. The Predictive Coding Account of Psychosis
The brain structures involved in deciding what deserves attention, known collectively as the salience network, show consistent abnormalities in schizophrenia. The anterior insula and anterior cingulate cortex, two key hubs for determining what is “important” in the stream of experience, show both structural and functional differences in brain imaging.13PubMed Central. Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction When these regions do not function properly, the brain may assign significance to random noise, internal thoughts, or irrelevant stimuli, producing the sense that ordinary events carry hidden meaning or that imagined perceptions are real.
Sleep Disruption as Both a Symptom and a Mechanism
Sleep problems in psychosis are not just a side effect of distress. They appear to be tied to the underlying biology. People with schizophrenia, and even their unaffected relatives, show a specific reduction in sleep spindles, the brief bursts of brain activity during non-REM sleep that help consolidate memories. This spindle deficit correlates with positive symptoms like hallucinations and with impaired thalamocortical connectivity, the signaling between deep brain structures and the cortex.14PubMed Central. Abnormal Sleep Spindles, Memory Consolidation, and Schizophrenia
A large meta-analysis confirmed that spindle abnormalities, including reduced density, amplitude, and duration, are present across the clinical stages of psychosis, from early episodes through chronic illness.15JAMA Psychiatry. Sleep Abnormalities in Different Clinical Stages of Psychosis: A Systematic Review and Meta-analysis The fact that unaffected family members also show spindle deficits suggests this is not merely a consequence of medication or chronic illness but reflects something closer to the genetic roots of the condition. Poor sleep may also create a vicious cycle: disrupted memory consolidation could worsen cognitive symptoms, increase stress, and lower the threshold for psychotic episodes.
Autoimmune Psychosis and the NMDA Connection
One of the most surprising discoveries in recent psychiatry is that some cases of apparent psychosis are actually caused by the immune system attacking the brain. In anti-NMDA receptor encephalitis, the body produces antibodies that target NMDA receptors, effectively pulling them out of commission. Patients often present first with psychiatric symptoms, particularly psychosis, and the condition can be misdiagnosed as a primary psychiatric disorder.16PubMed Central. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis Case reports describe young adults initially treated for psychiatric illness before the autoimmune cause was identified.17Academic Anesthesia. Anti-NMDA Receptor Encephalitis Initially Misdiagnosed as Psychiatric Illness: Implications for Perioperative and Critical Care Management
This matters for two reasons. First, autoimmune psychosis is treatable with immunotherapy rather than antipsychotics, so missing the diagnosis means missing the correct treatment. Second, it provides a kind of natural experiment that confirms the importance of NMDA receptor function: when antibodies disable these receptors, psychosis results. It is the immune system doing precisely what the glutamate hypothesis predicts would cause problems.
The Prodrome and Why Timing Matters
Psychosis rarely arrives without warning. Most people pass through a “clinical high-risk” phase marked by attenuated symptoms: unusual thoughts that have not quite hardened into delusions, perceptual oddities that fall short of full hallucinations, and sometimes subtle negative symptoms like declining motivation.18European Psychiatry. Attenuated positive and negative symptoms in patients at clinical high-risk for psychosis Not everyone in this phase will go on to develop a full psychotic disorder, but recognizing it opens a window for intervention.
How long psychosis goes untreated makes a measurable difference to outcomes. A meta-analysis found that early intervention improved quality of life, employment, negative symptoms, relapse rates, and hospitalizations compared to standard care.19PubMed Central. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies Conversely, longer periods of untreated psychosis predicted worse functioning and more severe negative symptoms at follow-up.20Schizophrenia Bulletin. “Short” Versus “Long” Duration of Untreated Psychosis in People with First-Episode Psychosis: A Systematic Review and Meta-Analysis of Baseline Status and Follow-Up Outcomes The relationship is not just about medication. Early intervention programs typically combine antipsychotic treatment with therapy, family support, and help with employment and education, and the benefits appear to come from the package rather than any single component.
Treatments Beyond Dopamine
Because the dopamine-blocking approach to treatment leaves many patients with persistent symptoms, especially cognitive and negative symptoms, researchers have been developing drugs that work through entirely different mechanisms. Several new approaches are in advanced stages of development. One targets muscarinic receptors in the cholinergic system, exemplified by a drug candidate called KarXT, which modulates signaling through M1 and M4 receptors. Another targets trace amine-associated receptors (TAAR1). A third, iclepertin, inhibits a transporter involved in glutamate signaling and may become the first treatment specifically aimed at the cognitive impairment that accompanies schizophrenia.21PubMed. Beyond dopamine: Novel strategies for schizophrenia treatment
These newer approaches reflect how much the understanding of psychosis has broadened. If the only relevant brain chemical were dopamine, there would be no rationale for targeting acetylcholine receptors or trace amines. The fact that these alternative pathways show promise reinforces the idea that psychosis involves a network of interacting systems, not a single broken switch.
The Gut, the Immune System, and Emerging Frontiers
Research on the gut microbiome adds yet another layer. People with schizophrenia tend to have different gut bacteria compared to healthy controls, and those differences have been associated with symptom severity and disease progression.22PubMed Central. Gut Microbiome: A Brief Review on Its Role in Schizophrenia and First Episode of Psychosis The gut communicates with the brain through immune molecules, the vagus nerve, and metabolic products made by bacteria, so the idea that gut health could influence psychosis is biologically plausible. The field is still young, though, and no consistent pattern of specific microbial changes has been pinned down. It is better understood as a promising research direction than a clinical tool at this point.
Meanwhile, computational models have started to demonstrate how sensory deprivation alone can produce hallucination-like activity in neural networks. In one study, when inputs to a simulated network were cut off in a certain frequency range, the network’s internal connections adapted in a way that produced spontaneous activity patterns independent of actual input, a computational analog of hallucination.23PLOS Computational Biology. Tinnitus-like “hallucinations” elicited by sensory deprivation in an entropy maximization recurrent neural network This fits with human experience: prolonged sensory deprivation or isolation can produce hallucinations even in people with no psychiatric history, which suggests the brain’s tendency to “fill in the gaps” when input is lacking is a fundamental feature of how neural circuits operate, not a unique pathology.
Why Schizophrenia Risk Genes Persist
A puzzling question has nagged researchers for decades: if psychotic disorders are so debilitating, why haven’t the contributing genes been eliminated by natural selection? One line of evidence suggests that many genetic variants associated with schizophrenia overlap with markers of recent human evolution, including genes related to brain size and cognitive complexity.24PubMed Central. Genetic markers of human evolution are enriched in schizophrenia The implication is uncomfortable but interesting: the same genetic architecture that enabled distinctly human cognitive abilities may, in certain combinations and under certain environmental conditions, tip into the territory of psychosis. The genes persist not because psychosis is beneficial but because the broader cognitive toolkit they support is. In this view, psychosis is not so much a disease that evolution failed to remove as a risk inherent in the kind of brain evolution built.